Literature DB >> 34917238

Novel Compounds as PHD Inhibitors for Treating Heart, Lung, Liver, and Kidney Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917238      PMCID： PMC8667062          DOI： 10.1021/acsmedchemlett.1c00570

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.

Authors:  Mengchao Yu; Jie Lun; Hongwei Zhang; Lei Zhu; Gang Zhang; Jing Fang
Journal:  Int J Biochem Cell Biol       Date:  2021-04-21       Impact factor: 5.085

Review 2.  Anemia: A Connection Between Heart Failure and Kidney Failure.

Authors:  Francesco Locatelli; Lucia Del Vecchio; Roberto Minutolo; Luca De Nicola
Journal:  Cardiol Clin       Date:  2021-08       Impact factor: 2.213

Review 3.  HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy?

Authors:  Diana Gaete; Diego Rodriguez; Deepika Watts; Sundary Sormendi; Triantafyllos Chavakis; Ben Wielockx
Journal:  Cancers (Basel)       Date:  2021-02-27       Impact factor: 6.639

Review 4.  ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?

Authors:  Lucia Del Vecchio; Roberto Minutolo
Journal:  J Clin Med       Date:  2021-02-18       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.